CLOV CLOVER HEALTH INV CORP

Clover Health Promotes Karen Soares to General Counsel

Clover Health Promotes Karen Soares to General Counsel

FRANKLIN, Tenn., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced the appointment of Karen Soares as General Counsel, effective October 31, 2023. Karen will serve on Clover’s management team and will report to Andrew Toy, Chief Executive Officer of Clover.

“Karen has been a tremendous asset to Clover over the years, providing strategic legal counsel and partnership as our business has continued to evolve. I’m delighted to have her serve as our General Counsel, as Clover will benefit from her healthcare expertise and deep understanding of our business as we continue to deliver on our mission,” said Toy.

Soares first joined Clover in 2018 as an Associate General Counsel, supporting the contracting, compliance, and product functions. She has served in many positions at the company since that time, most recently serving as Senior Vice President, Deputy General Counsel and successfully overseeing the company’s legal department on an interim basis. Prior to joining Clover, Soares held various legal and compliance positions with other organizations, including Analyte Health, a telehealth startup, and Fried, Frank, Harris, Shriver & Jacobson LLP. She received her B.A. from Dartmouth College, and her J.D. from the University of Chicago Law School.

“Over the past five years, I have had the privilege of working with the talented team at Clover as we work toward our mission to improve every life. I am honored and excited to step into the role of Clover’s General Counsel as we continue on this important journey,” Soares said.

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. Our Non-Insurance line of business similarly aims to reduce cost-of-care while enhancing the quality of care for patients enrolled in Original Medicare.

Press Contact:

Andrew Still-Baxter

Investor Relations Contact:

Ryan Schmidt



EN
01/11/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE

Clover Health Reports Second Quarter 2025 Results; Delivering Strong S...

Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth Second quarter 2025 Medicare Advantage membership of 106,323, up 32% year-over-yearSecond quarter 2025 Total revenues of $478 million, up 34% year-over-yearSecond quarter 2025 profitability metrics with GAAP Net loss of $11 million, Adjusted EBITDA of $17 million, and Adjusted Net income of $17 million Updates Full Year 2025 Guidance: Increases Average Medicare Advantage membership to 104,000 - 108,000, representing 32% growth year-over-year at the midpointMaintains Insurance revenue between $1.800...

 PRESS RELEASE

Primary Care Physician Use of Counterpart Assistant Technology Linked ...

Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and meaningful reductions in hospitalizations (15% lower) and 30-day readmissions (18% lower). WILMINGTON, Del., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary o...

 PRESS RELEASE

Clover Health Applauds White House and CMS’ Push to “Tear Down Digital...

Clover Health Applauds White House and CMS’ Push to “Tear Down Digital Walls,” Accelerating and Simplifying Access to Health Data for Patients and Their Clinicians Clover Health’s AI platform, Counterpart Assistant, already connects to a majority of the data networks named in yesterday’s pledge – eliminating the “digital walls,” delivering proven outcomes in chronic disease care, and supporting independent doctors caring for seniors in rural and other underserved areas WILMINGTON, Del., July 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), ...

 PRESS RELEASE

Counterpart Health Appoints Vicky Bruner as Vice President of Operatio...

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today announced the appointment of Vicky Bruner as Vice President of Operations. As Counterpart scales to meet growing demand from payors and providers nationwide, Bruner will lead several critical functio...

 PRESS RELEASE

Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual...

Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 11:00 a.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch